The store will not work correctly when cookies are disabled.
l-(Cyclohexylmethyl)-3-(5-nitrothiazol-2-yl)urea
ID: ALA4550440
PubChem CID: 126611747
Max Phase: Preclinical
Molecular Formula: C11H16N4O3S
Molecular Weight: 284.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NCC1CCCCC1)Nc1ncc([N+](=O)[O-])s1
Standard InChI: InChI=1S/C11H16N4O3S/c16-10(12-6-8-4-2-1-3-5-8)14-11-13-7-9(19-11)15(17)18/h7-8H,1-6H2,(H2,12,13,14,16)
Standard InChI Key: VBKKNDVFPAIPBD-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
11.0689 -10.1102 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.2439 -10.1102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8314 -10.8247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8314 -9.3958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.5215 -8.7283 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.0064 -9.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5215 -10.0632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7369 -9.8083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7369 -8.9833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0694 -8.4984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1557 -7.6779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3158 -8.8339 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4814 -10.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3064 -10.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7189 -10.1102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5439 -10.1102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9564 -10.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5439 -11.5392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7189 -11.5392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
5 9 1 0
10 11 2 0
10 12 1 0
9 10 1 0
4 6 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
14 19 1 0
13 14 1 0
1 13 1 0
M CHG 2 10 1 12 -1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 284.34 | Molecular Weight (Monoisotopic): 284.0943 | AlogP: 2.75 | #Rotatable Bonds: 4 |
Polar Surface Area: 97.16 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.53 | CX Basic pKa: ┄ | CX LogP: 2.66 | CX LogD: 2.44 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.66 | Np Likeness Score: -2.20 |
References
1. (2017) Compounds and methods for treatment of cancer by inhibiting atg4b and blocking autophagy, |